rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas (tc) Chan

Chief Accounting Officer

Company insider

Files Form 4 as: Chief Accounting Officer, GoodRx Holdings.

In numbers

Trades disclosed
71
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
11 May 2026
Last trade
15 Oct 2026
Last filed
15 Oct 2026

Companies traded

Where they are an officer
GDRX GoodRx HoldingsOfficer · Payments & Processors · last 15 Oct 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—5,793filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$9,9642,948 at $3.38filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—5,793 at $0.00filing
15 Sep 2026filed 15 Sep 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—2,101filing
15 Sep 2026filed 15 Sep 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$3,8061,069 at $3.56filing
15 Sep 2026filed 15 Sep 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—2,101 at $0.00filing
15 Sep 2026filed 15 Sep 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—2,101 at $0.00filing
15 Sep 2026filed 15 Sep 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—2,101filing
15 Sep 2026filed 15 Sep 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$3,8061,069 at $3.56filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—1,252filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—1,686 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—2,636 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—4,541 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$2,380638 at $3.73filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—1,686filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—1,252 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—1,686 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—2,636 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—4,541 at $0.00filing
15 Aug 2026filed 17 Aug 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$3,200858 at $3.73filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Justin FenglerOfficer · Officer at GoodRx Holdings, filing Form 4 there in the last year
Wendy Lynn BarnesDirector and Officer · Director and Officer at GoodRx Holdings, filing Form 4 there in the last year
FRANCISCO PARTNERS IV, L.P.10% owner · 10% owner at GoodRx Holdings, filing Form 4 there in the last year
Christopher A. McGinnisOfficer · Officer at GoodRx Holdings, filing Form 4 there in the last year
Douglas Joseph HirschDirector · Director at GoodRx Holdings, filing Form 4 there in the last year